Aminocandin exhibits a broad spectrum of activity against various Candida species and shows promising results in clinical trials. Aminocandin targets specific components of the fungal cell wall, disrupting its integrity and ultimately leading to cell death.
CAT No: R2038
CAS No:227472-48-2
Chemical Name:N-[(3S,6S,9S,11R,15S,18S,24S,25S,26S)-20-(2-aminoethylamino)-11,25-dihydroxy-15-[(1R)-1-hydroxyethyl]-6-[(1R)-1-hydroxy-2-(4-hydroxyphenyl)ethyl]-3-(hydroxymethyl)-26-methyl-2,5,8,14,17,23-hexaoxo-1,4,7,13,16,22-hexazatricyclo[22.3.0.09,13]heptacosan-18-yl]-4-(4-octoxyphenyl)benzamide
Aminocandin is a semisynthetic echinocandin lipopeptide, structurally characterized as a cyclic hexapeptide linked to a lipid side chain. As a member of the echinocandin class, it functions as a noncompetitive inhibitor of (1,3)-β-D-glucan synthase, a key enzyme in the biosynthesis of fungal cell walls. Its unique biochemical properties have made it a valuable tool in antifungal research, particularly for studies focused on cell wall integrity, fungal physiology, and the development of resistance mechanisms. Aminocandin's structural features and mode of action enable its use in a range of laboratory and industrial settings, supporting advanced investigations into fungal biology and the discovery of novel antifungal strategies.
Antifungal mechanism studies: Researchers employ aminocandin to probe the enzymatic pathways involved in fungal cell wall construction, specifically targeting (1,3)-β-D-glucan synthase. By inhibiting this enzyme, the compound disrupts the synthesis of an essential polysaccharide component in the fungal cell wall, leading to weakened structural integrity. This property makes it an excellent tool for dissecting cell wall biosynthesis and understanding the molecular mechanisms underlying fungal growth and survival.
Resistance development research: The compound is frequently used in laboratory models to investigate the emergence and molecular basis of antifungal resistance. By exposing fungal cultures to aminocandin under controlled conditions, scientists can monitor adaptive responses, identify mutations in target enzymes, and elucidate compensatory pathways that confer reduced susceptibility. These studies are critical for anticipating resistance trends and informing the design of next-generation antifungal agents.
Synergistic combination studies: In the context of combination therapy research, aminocandin is utilized to evaluate potential synergistic or antagonistic interactions with other antifungal compounds. Its distinct mechanism, targeting the fungal cell wall, complements agents acting on different cellular processes, allowing researchers to assess additive or potentiating effects. Such investigations provide valuable insight into optimal drug pairing strategies and enhance understanding of multi-targeted antifungal interventions.
Fungal cell biology and physiology assays: The compound serves as a selective probe in studies examining the broader physiological consequences of cell wall inhibition. By perturbing cell wall assembly, it enables researchers to investigate downstream effects on fungal morphology, osmotic stability, and stress responses. These applications contribute to a deeper understanding of fungal adaptation to environmental challenges and the interplay between cell wall integrity and cellular homeostasis.
Screening and validation of antifungal targets: Aminocandin is also applied in high-throughput screening platforms and validation assays aimed at identifying novel inhibitors of (1,3)-β-D-glucan synthase or related pathways. Its well-characterized mode of action and robust activity profile make it a reliable reference compound for benchmarking the efficacy of new antifungal candidates. Through these applications, it supports the ongoing search for innovative antifungal agents and the expansion of the antifungal drug discovery pipeline.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More